- Home
- OUT vs XENE Comparison
OUT vs XENE Comparison
Compare OUT & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUT
- XENE
- Stock Information
- Founded
- OUT 2013
- XENE 1996
- Country
- OUT United States
- XENE Canada
- Employees
- OUT N/A
- XENE N/A
- Industry
- OUT Real Estate Investment Trusts
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- OUT Real Estate
- XENE Health Care
- Exchange
- OUT Nasdaq
- XENE Nasdaq
- Market Cap
- OUT 2.4B
- XENE 2.5B
- IPO Year
- OUT N/A
- XENE 2014
- Fundamental
- Price
- OUT $15.40
- XENE $35.54
- Analyst Decision
- OUT Buy
- XENE Strong Buy
- Analyst Count
- OUT 7
- XENE 9
- Target Price
- OUT $19.55
- XENE $56.22
- AVG Volume (30 Days)
- OUT 1.4M
- XENE 862.0K
- Earning Date
- OUT 05-08-2025
- XENE 05-12-2025
- Dividend Yield
- OUT 10.74%
- XENE N/A
- EPS Growth
- OUT N/A
- XENE N/A
- EPS
- OUT 1.51
- XENE N/A
- Revenue
- OUT $1,830,900,000.00
- XENE N/A
- Revenue This Year
- OUT $0.88
- XENE N/A
- Revenue Next Year
- OUT $3.57
- XENE $1,553.36
- P/E Ratio
- OUT $10.33
- XENE N/A
- Revenue Growth
- OUT 0.57
- XENE N/A
- 52 Week Low
- OUT $12.95
- XENE $26.74
- 52 Week High
- OUT $19.98
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- OUT 50.62
- XENE 49.08
- Support Level
- OUT $15.40
- XENE $37.46
- Resistance Level
- OUT $15.87
- XENE $39.01
- Average True Range (ATR)
- OUT 0.39
- XENE 1.68
- MACD
- OUT 0.16
- XENE -0.14
- Stochastic Oscillator
- OUT 73.74
- XENE 48.59
About OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.